Reference Materials

Shop By
View as List Grid

8 Items

Set Descending Direction
  1. Apigenin, Activator of CFTR
    Cas#: 520-36-5        Compound CID:  5280443
    Formula:  C15H10O5        Molecular Weight: 270.24
    IUPAC Name: 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
    SMILES: C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O
    InChIKey: KZNIFHPLKGYRTM-UHFFFAOYSA-N
    InChI: InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H
    Synonyms: Chamomile | Apigenine | Versulin | 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one | 5,7-dihydroxy-2-(4-hydroxyphe...
  2. Resveratrol, Inhibitor of COX-2;Agonist of TAS2R14;Antagonist of Peroxisome proliferator-activated receptor-γ
    Cas#: 501-36-0        Compound CID:  445154
    Formula:  C14H12O3        Molecular Weight: 228.24
    IUPAC Name: 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
    SMILES: C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
    InChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N
    InChI: InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
    Synonyms: Q369O8926L | CHEBI:27881 | CU-01000001503-3 | HMS1792H15 | NSC133100 | BPBio1_000479 | NCGC00344093-09 | RESVERATROL ...
  3. Myricetin
    Cas#: 529-44-2        Compound CID:  5281672
    Formula:  C15H10O8        Molecular Weight: 318.24
    IUPAC Name: 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
    SMILES: C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O
    InChIKey: IKMDFBPHZNJCSN-UHFFFAOYSA-N
    InChI: InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H
    Synonyms: BIDD:PXR0079 | NCGC00015697-01 | NCGC00179517-01 | FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY- | NCGC00015697-07 | Myricetin...
  4. Curcumin, Inhibitor of E1A binding protein p300;Activator of TRPV4
    Cas#: 458-37-7        Compound CID:  969516
    Formula:  C21H20O6        Molecular Weight: 368.38
    IUPAC Name: (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
    SMILES: COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O
    InChIKey: VFLDPWHFBUODDF-FCXRPNKRSA-N
    InChI: InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+
    Synonyms: BIDD:ER0479 | Golden seal | NSC 687842 | Ukon (dye) | Victory 19 Virus Out | CURCUMIN (MART.) | Yellow Ginger | Zlut ...
  5. (-)-Epigallocatechin gallate
    Cas#: 989-51-5        Compound CID:  65064
    Formula:  C22H18O11        Molecular Weight: 458.37
    IUPAC Name: [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
    SMILES: C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O
    InChIKey: WMBWREPUVVBILR-WIYYLYMNSA-N
    InChI: InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1
    Synonyms: EGCG | 3-O-Gallate
  6. Aminoacetic acid, Agonist of GluN1;Agonist of GluN2A;Agonist of GluN2B;Agonist of GluN2C;Agonist of GluN2D;Agonist of GPRC6 receptor
    Cas#: 56-40-6        Compound CID:  750
    Formula:  NH2CH2COOH        Molecular Weight: 75.07
    IUPAC Name: 2-aminoacetic acid
    SMILES: C(C(=O)O)N
    InChIKey: DHMQDGOQFOQNFH-UHFFFAOYSA-N
    InChI: InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
    Synonyms: EINECS 200-272-2 | Aciport | Padil | [3H]glycine | GLYCINE (USP MONOGRAPH) | Glycine [USP:INN] | Tocris-0219 | GLYCIN...
  7. Luteolin, Agonist of TAS2R14;Agonist of TAS2R39
    Cas#: 491-70-3        Compound CID:  5280445
    Formula:  C15H10O6        Molecular Weight: 286.24
    IUPAC Name: 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
    SMILES: C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O
    InChIKey: IQPNAANSBPBGFQ-UHFFFAOYSA-N
    InChI: InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H
    Synonyms: Digitoflavone | Luteolol | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
per page

We noticed your location and want to make sure you’re viewing the most relevant version of our site.
Would you like to be redirected to your local region’s page for a smoother experience?